Andrew P Grigg Selected Research

Andrew P Grigg Research Topics

6	Neoplasms (Cancer) 01/2019 - 02/2002
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2018 - 11/2011
3	Thrombosis (Thrombus) 07/2019 - 07/2005
2	Vascular System Injuries 07/2019 - 09/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2010 - 02/2002
2	Infections 05/2005 - 11/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2021
1	Necrosis 07/2019
1	Leukemia 12/2018
1	Peripheral Arterial Occlusive Disease 1 09/2016
1	Carotid Artery Injuries 09/2016
1	Hematologic Neoplasms (Hematological Malignancy) 12/2015
1	Melanoma (Melanoma, Malignant) 12/2015
1	Residual Neoplasm 07/2013
1	Fatigue 04/2010
1	Thrombocytosis (Thrombocythemia) 08/2006
1	Hemorrhage 07/2005
1	Essential Thrombocythemia 07/2005
1	Primary Myelofibrosis (Myelosclerosis) 07/2005
1	Venous Thromboembolism 07/2005
1	Abdominal Pain (Pain, Abdominal) 01/2004
1	Neutropenia 01/2004
1	Bacteremia 01/2004
1	Septic Shock (Toxic Shock Syndrome) 01/2004
1	Fever (Fevers) 01/2004
1	Diarrhea 01/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2003
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2002

4	Imatinib Mesylate (Gleevec)FDA Link 07/2019 - 11/2011
4	fludarabineIBA 05/2005 - 02/2002
3	InterferonsIBA 07/2019 - 04/2010
3	Dasatinib (BMS 354825)FDA Link 07/2019 - 11/2011
2	nilotinib FDA Link 07/2019 - 09/2016
2	Melphalan (Alkeran)FDA LinkGeneric 04/2010 - 07/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2005 - 11/2004
1	AzolesIBA 01/2022
1	venetoclaxIBA 01/2022
1	Thromboxane B2IBA 07/2019
1	P-SelectinIBA 07/2019
1	Interleukin-6 (Interleukin 6)IBA 07/2019
1	CollagenIBA 07/2019
1	ponatinibIBA 07/2019
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Collagen Type I (Type I Collagen)IBA 09/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2015
1	Busulfan (Busulfex)FDA Link 04/2010
1	Interferon-alpha (Interferon Alfa)IBA 04/2010
1	AnthracyclinesIBA 04/2010
1	Biological ProductsIBA 08/2006
1	anagrelide (Agrylin)FDA LinkGeneric 07/2005
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2005
1	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2005
1	Rituximab (Mabthera)FDA Link 05/2005
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2004
1	Anti-Infective Agents (Microbicides)IBA 01/2004
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2004
1	PlatinumIBA 02/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002
1	Cisplatin (Platino)FDA LinkGeneric 02/2002
1	NucleosidesIBA 02/2002
1	DNA AdductsIBA 02/2002

5	Therapeutics 01/2022 - 11/2004
1	Drug Therapy (Chemotherapy) 04/2010
1	Combination Drug Therapy (Combination Chemotherapy) 11/2004
1	Stem Cell Transplantation 07/2003
1	Hematopoietic Stem Cell Transplantation 07/2003
1	Salvage Therapy 02/2002